BE898882A - Nouvelle preparation retard contenant de la n''-cyano-n-4-pirydil-n'-1,2,2-trimethylpropylguanidine, utile notamment dans le traitement de l'hypertension. - Google Patents

Nouvelle preparation retard contenant de la n''-cyano-n-4-pirydil-n'-1,2,2-trimethylpropylguanidine, utile notamment dans le traitement de l'hypertension.

Info

Publication number
BE898882A
BE898882A BE0/212368A BE212368A BE898882A BE 898882 A BE898882 A BE 898882A BE 0/212368 A BE0/212368 A BE 0/212368A BE 212368 A BE212368 A BE 212368A BE 898882 A BE898882 A BE 898882A
Authority
BE
Belgium
Prior art keywords
pirydil
trimethylpropylguanidine
hypertension
cyano
treatment
Prior art date
Application number
BE0/212368A
Other languages
English (en)
Inventor
E J Didriksen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of BE898882A publication Critical patent/BE898882A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

La préparation retard est caractérisée en ce que les composants actifs sont contenus dans au moins deux types différents de pellets, le premier comportant une substance d'encapsulation insoluble mais perméable dans les fluides du tube gastro-intestinal et consistant en un copolymère d'esters acryliques et méthacryliques à faible teneur en groupes ammonium quaternaire et le second comportant une matière d'encapsulation qui, après érosion dans l'intestin, libère les composants actifs, ce second type de matière d'encapsulation consistant en un copolymère anionique d'acide méthacrylique et d'esters méthacryliques.
BE0/212368A 1983-02-11 1984-02-10 Nouvelle preparation retard contenant de la n''-cyano-n-4-pirydil-n'-1,2,2-trimethylpropylguanidine, utile notamment dans le traitement de l'hypertension. BE898882A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK0589/83A DK58983D0 (da) 1983-02-11 1983-02-11 Farmaceutisk praeparat

Publications (1)

Publication Number Publication Date
BE898882A true BE898882A (fr) 1984-08-10

Family

ID=8095276

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212368A BE898882A (fr) 1983-02-11 1984-02-10 Nouvelle preparation retard contenant de la n''-cyano-n-4-pirydil-n'-1,2,2-trimethylpropylguanidine, utile notamment dans le traitement de l'hypertension.

Country Status (15)

Country Link
US (1) US4600577A (fr)
JP (1) JPS59155312A (fr)
BE (1) BE898882A (fr)
DE (1) DE3404595A1 (fr)
DK (1) DK58983D0 (fr)
ES (1) ES8608490A1 (fr)
FR (1) FR2540727B1 (fr)
GB (1) GB2134785B (fr)
IE (1) IE56604B1 (fr)
IT (1) IT1196682B (fr)
NL (1) NL8400430A (fr)
NZ (1) NZ207010A (fr)
PH (1) PH21734A (fr)
SE (1) SE447871B (fr)
ZA (1) ZA84856B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US5286494A (en) * 1986-07-02 1994-02-15 Schering Aktiengesellschaft Medicinal agents with sustained action
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
EP0579260A1 (fr) * 1987-07-07 1994-01-19 Beecham Group Plc Utilisation d'un vasodilatateur pour le traitement de l'hypertension pulmonale et/ou des conditions relatés au cor pulmonale
US5009894A (en) * 1988-03-07 1991-04-23 Baker Cummins Pharmaceuticals, Inc. Arrangement for and method of administering a pharmaceutical preparation
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
DE59905248D1 (de) 1999-01-29 2003-05-28 Disphar Int Bv Pharmazeutische zusammensetzungen
US6210716B1 (en) * 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation
US6417207B1 (en) 1999-05-12 2002-07-09 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US6897205B2 (en) * 2001-01-31 2005-05-24 Roehm Gmbh & Co. Kg Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
WO2009049160A1 (fr) 2007-10-12 2009-04-16 Takeda Pharmaceuticals North America Procédés de traitement de troubles gastro-intestinaux indépendants de la prise alimentaire

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
JPS54129115A (en) * 1978-03-31 1979-10-06 Yasuyo Miyauchi Long acting amoxycilin preparation
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
FR2477015A1 (fr) * 1980-03-03 1981-09-04 Fabre Sa Pierre Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
EP0052075A1 (fr) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Granule pharmaceutique à action retardée
DE3127984A1 (de) * 1981-07-15 1983-02-03 Klinge Pharma GmbH, 8000 München Orale arzneimittel fuer die kariesprophylaxe

Also Published As

Publication number Publication date
FR2540727B1 (fr) 1987-01-23
NZ207010A (en) 1987-06-30
GB8403572D0 (en) 1984-03-14
DK58983D0 (da) 1983-02-11
SE8400723D0 (sv) 1984-02-10
FR2540727A1 (fr) 1984-08-17
JPH0451528B2 (fr) 1992-08-19
SE447871B (sv) 1986-12-22
PH21734A (en) 1988-02-10
GB2134785A (en) 1984-08-22
IT1196682B (it) 1988-11-25
ES529660A0 (es) 1986-06-16
SE8400723L (sv) 1984-08-12
ES8608490A1 (es) 1986-06-16
NL8400430A (nl) 1984-09-03
IE56604B1 (en) 1991-10-09
JPS59155312A (ja) 1984-09-04
DE3404595A1 (de) 1984-08-16
ZA84856B (en) 1984-09-26
IT8467131A0 (it) 1984-02-13
US4600577A (en) 1986-07-15
GB2134785B (en) 1986-07-02
IE840146L (en) 1984-08-11
DE3404595C2 (fr) 1993-04-29
IT8467131A1 (it) 1985-08-13

Similar Documents

Publication Publication Date Title
BE898882A (fr) Nouvelle preparation retard contenant de la n''-cyano-n-4-pirydil-n'-1,2,2-trimethylpropylguanidine, utile notamment dans le traitement de l'hypertension.
ATE294575T1 (de) Mehrfach ungesättigte omega-3 fettsäuren zur behandlung von entzündlichen darmerkrankungen in kapseln mit zeitabhängiger freisetzung
FI823975L (fi) Farmaceutisk flerenhetssammansaettning
FR2419072A1 (fr) Nouvelles compositions pharmaceutiques a base d'un peptide monocyclique
DE3684354D1 (de) Arzneimittel, die hohle, feine, roehrchenfoermige wirkstoffabgabesysteme enthalten.
KR910009243A (ko) 치근막 질환 치료용 서방성 조성물
FR2601876B1 (fr) Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et de l'acide citrique
DE69013216D1 (de) Herstellung von Stearidonsäure.
KR870008594A (ko) 베라파밀제형
KR880008804A (ko) 교미성이 개선된 경구 투여용 제제
KR920700048A (ko) 항혈전성 혈액처리 시스템
GB2090529A (en) Thrombosis-prophylactic and curing agent
BE1000735A5 (fr) Procede de preparation de capsules de gelatine molle de stabilite elevee.
IT8321348A0 (it) Agente per intensificare l'azione antitumorale di un agente antitumorale.
OA09137A (fr) Nouveaux dérivés de la benzoxazolinone, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
RU93043304A (ru) Кормовые или медикаментозные композиции для жвачных животных и способ их получения
FR2373288A1 (fr) Preparation pharmaceutique a liberation prolongee
FR2526418B1 (fr) Composition propulsive contenant de la nitrocellulose, de la nitroglycerine, du benzoate de cuivre et du plomb ou ses derives, notamment pour fusees
Chan et al. Metabolism of methotrexate in man after high and conventional doses
FR2396514A1 (fr) Gomme a macher a effet sucre persistant
PT76348A (fr) Isomere levogyre de la mequitazine son procede de preparation et medicaments le contenant
BE901963A (fr) Forme dosee d'etoposide a usage oral.
Schmidt et al. Severe enterobiasis in a chimpanzee
FR2530624B1 (fr) Nouveaux analogues de la vitamine d et compositions pharmaceutiques ou veterinaires les contenant
AU666961B2 (en) Method for the safe administration of fatty acid

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: LEO PHARMACEUTICAL PRODUCTS LTD A/S LOVENS KEMIS

Effective date: 20020228